FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1600965850> ?p ?o ?g. }

• W1600965850 endingPage "8528" @default.
• W1600965850 startingPage "8520" @default.
• W1600965850 abstract "In order to ascertain the role of phospholipase A2 (PLA2) in the release of arachidonic acid for eicosanoid biosynthesis, we have characterized a Ca2+-dependent PLA2 from P388D1 cells, evaluated inhibitors of its activity, and correlated the effects of these inhibitors on prostaglandin (PG) E2 production in the intact cell. The Ca2+-dependent PLA2 has little preference for the polar head group or sn-2 fatty acid of phospholipids, and we have now found that it will hydrolyze 1-alkyl,2-acyl phospholipids, but it does not show a preference for this substrate over other phospholipids. Inhibitor studies with the Ca2+-dependent PLA2 have shown that arachidonic acid is an effective inhibitor. The analogs of natural fatty acids, eicosatetraynoic acid and octadecyleicosaynoic acid, were ineffective as inhibitors of the P388D1 PLA2. However, 7,7-dimethyl-5,8-eicosadienoic acid was as effective an inhibitor (IC50 = 16 microM) as arachidonic acid. Manoalide and its analog, manoalogue, were found to be good inhibitors of the P388D1 PLA2 (IC50 = 16 and 26 microM, respectively). The irreversible inhibitor of the extracellular PLA2, p-bromophenacyl bromide, was a very poor inhibitor of the P388D1 PLA2, apparent IC50 = 500-600 microM. Quinacrine was also ineffective as an inhibitor as was the cyclooxygenase inhibitor indomethacin. On the cellular level, the P388D1 cells respond to various stimuli to produce PGD2 and PGE2 as the major cyclooxygenase products with minor production of PGI2 and thromboxane A2. Similar arachidonic acid metabolite profiles were seen for calcium ionophore A23187, melittin, and platelet-activating factor. Manoalide, manoalogue, and 7,7-dimethyl-5,8-eicosadienoic acid, effective inhibitors of the isolated PLA2, inhibited PGE2 production in intact P388D1 cells 40-85% in the concentration range studied. In contrast, p-bromophenacyl bromide, which is ineffective as an inhibitor of the P388D1 PLA2, did not significantly effect PGE2 production in the concentration ranges used. These results demonstrate that there may be important differences between the intracellular P388D1 PLA2 and the more commonly studied extracellular forms of PLA2. These differences are also observed in the intact cell studies and emphasize the need for the evaluation of inhibitors both in vitro and in vivo using the isolated enzyme and intact cell. This is the first example of studies aimed at correlating the inhibition of a purified intracellular PLA2 with inhibition of prostaglandin production in the intact cell from which it is derived." @default.
• W1600965850 created "2016-06-24" @default.
• W1600965850 creator A5040517890 @default.
• W1600965850 creator A5060937209 @default.
• W1600965850 creator A5065320926 @default.
• W1600965850 creator A5085618797 @default.
• W1600965850 date "1989-05-01" @default.
• W1600965850 modified "2023-10-18" @default.
• W1600965850 title "Inhibition Studies on the Membrane-associated Phospholipase A2 in vitro and Prostaglandin E2 Production in vivo of the Macrophage-like P388D1 Cell" @default.
• W1600965850 cites W1482693857 @default.
• W1600965850 cites W1483715738 @default.
• W1600965850 cites W1486343182 @default.
• W1600965850 cites W1492252673 @default.
• W1600965850 cites W1527233498 @default.
• W1600965850 cites W1527565099 @default.
• W1600965850 cites W1534835325 @default.
• W1600965850 cites W1565061217 @default.
• W1600965850 cites W1575117442 @default.
• W1600965850 cites W1576209843 @default.
• W1600965850 cites W1579911888 @default.
• W1600965850 cites W1597623702 @default.
• W1600965850 cites W1604163804 @default.
• W1600965850 cites W1783676357 @default.
• W1600965850 cites W1975700203 @default.
• W1600965850 cites W1977620629 @default.
• W1600965850 cites W1986061675 @default.
• W1600965850 cites W1993336893 @default.
• W1600965850 cites W2015572460 @default.
• W1600965850 cites W2024762045 @default.
• W1600965850 cites W2025552807 @default.
• W1600965850 cites W2031347882 @default.
• W1600965850 cites W2037380939 @default.
• W1600965850 cites W2058373242 @default.
• W1600965850 cites W2058556541 @default.
• W1600965850 cites W2071371995 @default.
• W1600965850 cites W2076345055 @default.
• W1600965850 cites W2090805356 @default.
• W1600965850 cites W2092580183 @default.
• W1600965850 cites W2094589572 @default.
• W1600965850 cites W2293695516 @default.
• W1600965850 cites W2340093856 @default.
• W1600965850 cites W302906649 @default.
• W1600965850 cites W4211175188 @default.
• W1600965850 cites W4293247451 @default.
• W1600965850 doi "https://doi.org/10.1016/s0021-9258(18)81822-1" @default.
• W1600965850 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2498315" @default.
• W1600965850 hasPublicationYear "1989" @default.
• W1600965850 type Work @default.
• W1600965850 sameAs 1600965850 @default.
• W1600965850 citedByCount "106" @default.
• W1600965850 countsByYear W16009658502012 @default.
• W1600965850 countsByYear W16009658502013 @default.
• W1600965850 countsByYear W16009658502015 @default.
• W1600965850 countsByYear W16009658502016 @default.
• W1600965850 countsByYear W16009658502018 @default.
• W1600965850 countsByYear W16009658502023 @default.
• W1600965850 crossrefType "journal-article" @default.
• W1600965850 hasAuthorship W1600965850A5040517890 @default.
• W1600965850 hasAuthorship W1600965850A5060937209 @default.
• W1600965850 hasAuthorship W1600965850A5065320926 @default.
• W1600965850 hasAuthorship W1600965850A5085618797 @default.
• W1600965850 hasBestOaLocation W16009658501 @default.
• W1600965850 hasConcept C12554922 @default.
• W1600965850 hasConcept C134018914 @default.
• W1600965850 hasConcept C150903083 @default.
• W1600965850 hasConcept C181199279 @default.
• W1600965850 hasConcept C185592680 @default.
• W1600965850 hasConcept C202751555 @default.
• W1600965850 hasConcept C207001950 @default.
• W1600965850 hasConcept C2776551241 @default.
• W1600965850 hasConcept C2777956040 @default.
• W1600965850 hasConcept C2779244956 @default.
• W1600965850 hasConcept C41625074 @default.
• W1600965850 hasConcept C55493867 @default.
• W1600965850 hasConcept C86803240 @default.
• W1600965850 hasConcept C95444343 @default.
• W1600965850 hasConceptScore W1600965850C12554922 @default.
• W1600965850 hasConceptScore W1600965850C134018914 @default.
• W1600965850 hasConceptScore W1600965850C150903083 @default.
• W1600965850 hasConceptScore W1600965850C181199279 @default.
• W1600965850 hasConceptScore W1600965850C185592680 @default.
• W1600965850 hasConceptScore W1600965850C202751555 @default.
• W1600965850 hasConceptScore W1600965850C207001950 @default.
• W1600965850 hasConceptScore W1600965850C2776551241 @default.
• W1600965850 hasConceptScore W1600965850C2777956040 @default.
• W1600965850 hasConceptScore W1600965850C2779244956 @default.
• W1600965850 hasConceptScore W1600965850C41625074 @default.
• W1600965850 hasConceptScore W1600965850C55493867 @default.
• W1600965850 hasConceptScore W1600965850C86803240 @default.
• W1600965850 hasConceptScore W1600965850C95444343 @default.
• W1600965850 hasIssue "15" @default.
• W1600965850 hasLocation W16009658501 @default.
• W1600965850 hasOpenAccess W1600965850 @default.
• W1600965850 hasPrimaryLocation W16009658501 @default.
• W1600965850 hasRelatedWork W1826923758 @default.
• W1600965850 hasRelatedWork W1968427039 @default.
• W1600965850 hasRelatedWork W1979156653 @default.
• W1600965850 hasRelatedWork W1997484252 @default.

• next